Annual total expenses:
$603.39M+$15.74M(+2.68%)Summary
- As of today (July 1, 2025), PCRX annual total expenses is $603.39 million, with the most recent change of +$15.74 million (+2.68%) on December 31, 2024.
- During the last 3 years, PCRX annual total expenses has risen by +$194.69 million (+47.64%).
- PCRX annual total expenses is now at all-time high.
Performance
PCRX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$160.75M+$3.03M(+1.92%)Summary
- As of today (July 1, 2025), PCRX quarterly total expenses is $160.75 million, with the most recent change of +$3.03 million (+1.92%) on March 31, 2025.
- Over the past year, PCRX quarterly total expenses has increased by +$8.74 million (+5.75%).
- PCRX quarterly total expenses is now at all-time high.
Performance
PCRX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PCRX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.7% | +5.8% |
| 3 y3 years | +47.6% | +18.0% |
| 5 y5 years | +56.6% | +74.2% |
PCRX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.6% | at high | +12.5% |
| 5 y | 5-year | at high | +59.6% | at high | +97.9% |
| alltime | all time | at high | +1518.9% | at high | +1860.1% |
PCRX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $160.75M(+1.9%) |
| Dec 2024 | $603.39M(+2.7%) | $157.72M(+7.6%) |
| Sep 2024 | - | $146.62M(-0.3%) |
| Jun 2024 | - | $147.05M(-3.3%) |
| Mar 2024 | - | $152.00M(+3.2%) |
| Dec 2023 | $587.65M(-1.4%) | $147.28M(+3.1%) |
| Sep 2023 | - | $142.85M(-2.3%) |
| Jun 2023 | - | $146.20M(-3.4%) |
| Mar 2023 | - | $151.32M(-4.1%) |
| Dec 2022 | $595.90M(+45.8%) | $157.71M(+8.3%) |
| Sep 2022 | - | $145.69M(-6.8%) |
| Jun 2022 | - | $156.23M(+14.7%) |
| Mar 2022 | - | $136.26M(+19.2%) |
| Dec 2021 | $408.70M(+8.1%) | $114.33M(+19.0%) |
| Sep 2021 | - | $96.05M(-4.5%) |
| Jun 2021 | - | $100.60M(+3.0%) |
| Mar 2021 | - | $97.72M(-7.3%) |
| Dec 2020 | $378.13M(-1.9%) | $105.43M(+6.3%) |
| Sep 2020 | - | $99.17M(+22.1%) |
| Jun 2020 | - | $81.23M(-12.0%) |
| Mar 2020 | - | $92.30M(-14.3%) |
| Dec 2019 | $385.32M(+20.5%) | $107.75M(+13.8%) |
| Sep 2019 | - | $94.65M(+0.8%) |
| Jun 2019 | - | $93.92M(+5.5%) |
| Mar 2019 | - | $88.99M(+7.5%) |
| Dec 2018 | $319.80M(+4.3%) | $82.80M(+6.0%) |
| Sep 2018 | - | $78.14M(+1.0%) |
| Jun 2018 | - | $77.40M(-5.0%) |
| Mar 2018 | - | $81.45M(+15.5%) |
| Dec 2017 | $306.70M | $70.50M(-0.2%) |
| Sep 2017 | - | $70.65M(-14.1%) |
| Jun 2017 | - | $82.22M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $83.33M(+10.6%) |
| Dec 2016 | $308.39M(+28.7%) | $75.36M(-15.5%) |
| Sep 2016 | - | $89.22M(+17.3%) |
| Jun 2016 | - | $76.08M(+12.3%) |
| Mar 2016 | - | $67.73M(-3.4%) |
| Dec 2015 | $239.54M(+18.1%) | $70.13M(+22.8%) |
| Sep 2015 | - | $57.10M(-0.4%) |
| Jun 2015 | - | $57.33M(+4.3%) |
| Mar 2015 | - | $54.98M(+2.0%) |
| Dec 2014 | $202.83M(+46.1%) | $53.87M(+1.6%) |
| Sep 2014 | - | $53.03M(+6.1%) |
| Jun 2014 | - | $50.01M(+8.9%) |
| Mar 2014 | - | $45.92M(+5.8%) |
| Dec 2013 | $138.84M(+57.1%) | $43.38M(+20.3%) |
| Sep 2013 | - | $36.07M(+23.7%) |
| Jun 2013 | - | $29.15M(-3.6%) |
| Mar 2013 | - | $30.23M(+15.0%) |
| Dec 2012 | $88.38M(+70.7%) | $26.28M(+8.6%) |
| Sep 2012 | - | $24.19M(+27.5%) |
| Jun 2012 | - | $18.97M(+0.2%) |
| Mar 2012 | - | $18.94M(+18.9%) |
| Dec 2011 | $51.77M(+38.9%) | $15.93M(+25.5%) |
| Sep 2011 | - | $12.69M(+4.3%) |
| Jun 2011 | - | $12.17M(+10.8%) |
| Mar 2011 | - | $10.98M(+33.9%) |
| Dec 2010 | $37.27M(-14.4%) | $8.20M(-25.3%) |
| Sep 2010 | - | $10.98M(+26.5%) |
| Jun 2010 | - | $8.68M(-7.6%) |
| Mar 2010 | - | $9.40M(-22.3%) |
| Dec 2009 | $43.55M(-26.5%) | $12.09M(+22.4%) |
| Sep 2009 | - | $9.88M |
| Dec 2008 | $59.29M | - |
FAQ
- What is Pacira BioSciences annual total expenses?
- What is the all time high annual total expenses for Pacira BioSciences?
- What is Pacira BioSciences annual total expenses year-on-year change?
- What is Pacira BioSciences quarterly total expenses?
- What is the all time high quarterly total expenses for Pacira BioSciences?
- What is Pacira BioSciences quarterly total expenses year-on-year change?
What is Pacira BioSciences annual total expenses?
The current annual total expenses of PCRX is $603.39M
What is the all time high annual total expenses for Pacira BioSciences?
Pacira BioSciences all-time high annual total expenses is $603.39M
What is Pacira BioSciences annual total expenses year-on-year change?
Over the past year, PCRX annual total expenses has changed by +$15.74M (+2.68%)
What is Pacira BioSciences quarterly total expenses?
The current quarterly total expenses of PCRX is $160.75M
What is the all time high quarterly total expenses for Pacira BioSciences?
Pacira BioSciences all-time high quarterly total expenses is $160.75M
What is Pacira BioSciences quarterly total expenses year-on-year change?
Over the past year, PCRX quarterly total expenses has changed by +$8.74M (+5.75%)